Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Commentary & Opinion

Debate Over Thai Compulsory Licensing Will Undermine Drug Industry's Ability to Provide Medicines to Developing Countries, Editorial Says

May 14, 2007

Although pharmaceutical company Abbott Laboratories offers many of the world's poorest countries with a discounted price for its antiretroviral drug Kaletra, it continues to be "attacked as a price-gouging capitalist indifferent to the suffering of the poor," a Chicago Tribune editorial says. According to the editorial, the reason for this criticism is because Abbott is involved in an "escalating" intellectual property dispute over the compulsory licensing of Kaletra in Thailand. Thai officials' stance on compulsory licensing "suggests that this isn't just about price," the editorial says, adding, "It's about power. And it's a direct challenge to intellectual property protection -- which makes drug research and development viable for companies like Abbott." The "outcome of this and similar battles" will affect the ability of all drug makers to develop new medications and make them accessible in developing countries, the editorial says. It adds that if Thailand "ignores the patent and still gets access to discounted" Aluvia, the updated version of Kaletra, "other countries will be emboldened to follow suit." According to the Tribune, the "world's poor should hope Abbott prevails" because they will "suffer if Abbott and other companies no longer have incentives to invest in new drugs that would mainly help" developing countries (Chicago Tribune, 5/10).

Back to other news for May 2007


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement